These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11786911)

  • 1. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity.
    Burger KN; Staffhorst RW; de Vijlder HC; Velinova MJ; Bomans PH; Frederik PM; de Kruijff B
    Nat Med; 2002 Jan; 8(1):81-4. PubMed ID: 11786911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular architecture of nanocapsules, bilayer-enclosed solid particles of Cisplatin.
    Chupin V; de Kroon AI; de Kruijff B
    J Am Chem Soc; 2004 Oct; 126(42):13816-21. PubMed ID: 15493941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts.
    Staffhorst RW; van der Born K; Erkelens CA; Hamelers IH; Peters GJ; Boven E; de Kroon AI
    Anticancer Drugs; 2008 Aug; 19(7):721-7. PubMed ID: 18594214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin nanocapsules.
    de Kroon AI; Staffhorst RW; Kruijff Bd; Burger KN
    Methods Enzymol; 2005; 391():118-25. PubMed ID: 15721377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis.
    Hamelers IH; Staffhorst RW; Voortman J; de Kruijff B; Reedijk J; van Bergen en Henegouwen PM; de Kroon AI
    Clin Cancer Res; 2009 Feb; 15(4):1259-68. PubMed ID: 19228729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
    Bryde S; de Kroon AI
    Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity.
    Velinova MJ; Staffhorst RW; Mulder WJ; Dries AS; Jansen BA; de Kruijff B; de Kroon AI
    Biochim Biophys Acta; 2004 May; 1663(1-2):135-42. PubMed ID: 15157616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
    Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
    J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
    Limayem Blouza I; Charcosset C; Sfar S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
    Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
    Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transfection of hepatoma cells after encapsulation of plasmid DNA into negatively charged liposomes.
    Zhang HW; Zhang L; Sun X; Zhang ZR
    Biotechnol Bioeng; 2007 Jan; 96(1):118-24. PubMed ID: 16894635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells.
    Wang L; MacDonald RC
    J Liposome Res; 2011 Dec; 21(4):306-14. PubMed ID: 21457078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocapsules: a novel lipid formulation platform for platinum-based anti-cancer drugs.
    Hamelers IH; de Kroon AI
    J Liposome Res; 2007; 17(3-4):183-9. PubMed ID: 18027238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.